Generic placeholder image

Current Pharmaceutical Analysis

Editor-in-Chief

ISSN (Print): 1573-4129
ISSN (Online): 1875-676X

Research Article

Selective and Sensitive UHPLC Method for the Trace Analysis of Formaldehyde in Drug Substance Using Fused-core Column Technology and Detailed Pre-column Derivatization study

Author(s): Ravi Kiran Panchakarla, Punna Rao Ravi* and Kondapalli Venkata Gowri Chandra Sekhar*

Volume 17, Issue 2, 2021

Published on: 15 November, 2019

Page: [201 - 209] Pages: 9

DOI: 10.2174/1573412916666191116115424

Price: $65

conference banner
Abstract

Background: Formaldehyde is a key intermediate/reagent in the synthesis of many significant pharmaceutical compounds. It is genotoxic as it interacts with the DNA, RNA and hence there is a pressing need to develop sensitive analytical methods for its trace level determination.

Objective: The present study aims to develop a simple and robust Ultra-High-Performance Liquid Chromatographic (UHPLC) method for the trace level quantification of a carcinogen-formaldehyde, in pharmaceutical drug substance.

Methods: This method was developed on a conventional pre-column derivatization technique with brady’s reagent followed by fast analysis on fused core C18 Ascentis Express (150 × 4.6 mm, 2.7 μm) column using ultraviolet (UV) detection. Optimization of the derivatization reaction time was conducted in different pH conditions. The optimized analytical method was fully validated in accordance with the current International Conference on Harmonization (ICH) Q2 guidelines, which demonstrated the developed method to be fast, specific, linear, sensitive, repeatable, accurate and convenient for routine quality control.

Results: The developed method was linear, accurate and precise in the concentration of 12.8 ng/mL to 510.7 ng/mL. The LOD and LOQ were found to be 3.8 ng/mL and 12.8 ng/mL, respectively.

Conclusion: The developed UHPLC can be used effectively for trace level quantification of formaldehyde in drug substances or drug products.

Keywords: Active pharmaceutical ingredient, derivatization, formaldehyde, fused core column technology, UHPLC, validation.

Graphical Abstract


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy